Theralase® Technologies Inc. Seeks Partnerships for Latest Discovery A Breakthrough in the Fight Against Herpes Simplex Virus Theralase® Technologies Inc. is making waves in the pharmaceutical world with its latest discovery, RuvidarTM. This lead drug formulation has been proven to be more effective in destroying the Herpes Simplex Virus 1 (HSV-1) than the current standard…
Improved Outcomes in COVID-19 Patients with Opaganib Data from a post hoc analysis of a randomized, placebo-controlled, double-blind phase 2/3 study of oral opaganib in COVID-19 pneumonia has revealed promising results. The analysis, published in the peer-reviewed journal Microorganisms, shows a 62% reduction in mortality and a 21% improvement in time to room air for…
Big News in the Business World! Stockholm, September 3, 2024 By: Your Favorite Business Guru So, did you hear the latest buzz in the business world? Asahi Kasei Corporation has taken a bold move by acquiring more than 90 percent of the outstanding shares of Calliditas Therapeutics AB. They’re not stopping there – they want…
Welcome to the Bionomics Blog! Exciting News from Bionomics Hey there, fellow science enthusiasts! Have you heard the latest news from Bionomics Limited? They just announced that they will be participating and presenting at the H.C. Wainwright 26th Annual Global Investment Conference! This conference is a big deal in the biotechnology world, and Bionomics will…
Charmingly Eccentric Blog: The Walgreens Class Action Lawsuit Introduction San Diego, September 03, 2024 – Robbins Geller Rudman & Dowd LLP recently announced that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) securities between October 12, 2023 and June 26, 2024, have until September 10, 2024 to seek appointment as lead plaintiff of…
How Russia’s Military Went From Feared Power to Failing Force Expert Interview Ukraine’s invasion of the Kursk region has stunned many people – in Russia and beyond – for its success in capturing Russian territories. The once feared Russian military has found itself struggling to defend its borders and maintain control in the face of…
Oh, The Intrigue! A Restricted Announcement Unveiled What’s the Buzz All About? Have you ever stumbled upon a mysterious announcement that seems to be shrouded in secrecy and intrigue? Well, we have just the kind of news that will pique your curiosity and leave you craving for more details. Brace yourself for a rollercoaster ride…
Lead Plaintiff Deadline in CVS Class Action Lawsuit: What You Need to Know Overview Robbins Geller Rudman & Dowd LLP has announced that purchasers or acquirers of CVS Health Corporation securities have until September 10, 2024, to seek appointment as lead plaintiff in the CVS class action lawsuit. The lawsuit alleges violations of the Securities…
